Related Experiment Videos
Interleukin 12 breaks ultraviolet light induced immunosuppression by affecting CD8+ rather than CD4+ T cells
A Schwarz1, S Grabbe, K Mahnke
1Ludwig Boltzmann Institute for Cell Biology and Immunobiology of the Skin, Department of Dermatology, University Münster, Germany.
The Journal of Investigative Dermatology
|March 20, 1998
Summary
Interleukin-12 (IL-12) counteracts UV-induced immunosuppression by targeting CD8+ T cells. This cytokine treatment prevents the development or activity of these suppressor cells, breaking UV-induced tolerance and restoring immune responses.
Area of Science:
- Immunology
- Photobiology
- Cellular immunology
Background:
- Ultraviolet (UV) radiation suppresses the immune system, leading to immunosuppression and tolerance.
- UV-induced immunosuppression can be transferred via splenocytes and is associated with hapten-specific tolerance.
- Interleukin-12 (IL-12) has shown potential in preventing UV-mediated immune suppression.
Purpose of the Study:
- To elucidate the mechanisms by which IL-12 counteracts UV-induced immunosuppression.
- To identify the specific immune cells involved in UV-induced suppression transfer.
- To determine if IL-12 acts by inhibiting suppressor cells or inducing effector cells.
Main Methods:
- Adoptive transfer of splenocytes from UV-irradiated and/or IL-12 treated mice.
- Depletion studies using CD8+ and CD4+ T cell markers.
- Assessment of contact hypersensitivity sensitization in recipient mice.
Main Results:
- UV-induced immunosuppression is transferable via CD8+ T cells.
- IL-12 treatment of UV-exposed mice prevents the transfer of suppression.
- IL-12's effect is independent of CD4+ T cell induction and occurs even when suppressor cells have developed.
Conclusions:
- IL-12 breaks UV-induced tolerance primarily by inhibiting or inactivating CD8+ suppressor T cells.
- IL-12 does not appear to act by inducing CD4+ effector T cells to counteract UV suppression.
- These findings highlight a potential therapeutic mechanism for IL-12 in managing UV-induced immune dysregulation.